Olympus announced today that it launched its SecureFlex single-use fine needle biopsy device in Europe and in Japan.

The lone Massachusetts biotech to go public in 2025 is defying industry trends with significant workforce expansion and a ...

The cryoablation treatment is indicated for women aged 70 and above with early-stage, low-risk breast tumours.

Now, there's a new way to take the medication. Meet the “Hollywood Dose,” aka microdosing Accutane.